Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of an Active Strategy to Implement the Canadian CT Head Rule: Phase III

NCT00993252 is registered in ClinicalTrials.gov with Ottawa Hospital Research Institute as lead sponsor.

NCT NCT00993252
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00993252 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of an Active Strategy to Implement the Canadian CT Head Rule: Phase III
Lead sponsor
Ottawa Hospital Research Institute
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2003
Completion date
March 31, 2009
Enrollment
4,531 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

head injury